Pu-erh Tea Powder Preventive Effects on Cisplatin-Induced Liver Oxidative Damage in Wistar Rats

  • Zheng, Xiao-Nan (Graduate School of Tianjin University of Traditional Chinese Medicine) ;
  • Wang, Xiao-Wen (Institute of neurological disorders, Yuquan hospital, Tsinghua university) ;
  • Li, Li-Ya (Division of Medical Oncology, Department of Integrated Traditional and Western Medicine, China-Japan Friendship Hospital) ;
  • Xu, Zi-Wei (The George Institute for Global Health) ;
  • Huang, Hsin-Yi (Graduate School of Tianjin University of Traditional Chinese Medicine) ;
  • Zhao, Jin-Sheng (Graduate School of Tianjin Medical University) ;
  • Zhang, Duo (Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital) ;
  • Yin, Xu (The Central Hospital of Chengde City) ;
  • Sheng, Jun (Yunnan Agricultural University) ;
  • Tang, Jin-Tian (Institute of neurological disorders, Yuquan hospital, Tsinghua university)
  • Published : 2014.09.15


Background: Chemotherapy is one of the major means for control of malignancies, with cisplatin (CDDP) as one of the main agents, widely used for the treatment of various malignant solid tumors. However, prevention of hepatotoxicity from cisplatin is one of the urgent issues in cancer chemotherapy. In this study, we aimed to investigate the effects of pu-erh tea on hepatotoxicity through body weight and tissue antioxidant parameters like, liver coefficient, serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), malondialdehyde(MDA) and glutathione (GSH) levels, and light microscopic evaluation by histological findings. Materials and Methods: The rats were randomly divided into five groups: Control (n=10), cisplatin (3 mg/kg p.i., n=10), cisplatin+pu-erh (0.32 g/kg/day i.g., n=10), cisplatin+pu-erh (0.8 g/kg/day i.g., n=10) and cisplatin+pu-erh (1.6 g/kg/day i.g., n=10). Pu-erh tea powder was administrated for 31 consecutive days. The rats were sacrificed at the end on the second day after a single dose of cisplatin treatment for measuring indices. Results: Pu-erh tea powder exhibited a protective effect by decreasing MDA and GSH and increasing the SOD and GSH-PX levels and GSH-PX/MDA ratio in camparison with the control group. Besides, pu-erh tea was also able to alleviate the pathological damage to some extent. Conclusion: Pu-erh tea powder is protective against cisplatin-induced liver oxidative damages, especially at the medium dosage (0.8 g/kg/d).



  1. Abdelmeguid NE, Chmaisse HN, Abou Zeinab NS (2010). Silymarin ameliorates cisplatin-induced hepatotoxicity in rats: histopathological and ultrastructural studies. Pak J Biol Sci, 13, 463-79.
  2. Ajith TA, Abhishek G, Roshny D, et al (2009). Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice. Exp Toxicol Pathol, 61, 565-71.
  3. Bentli R, Parlakpinar H, Polat A, et al (2013). Molsidomine prevents cisplatin-induced hepatotoxicity. Arch Med Res, 44, 521-8.
  4. Besse B, Heist RS, Papadmitrakopoulou VA, et al (2014). A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer. Ann Oncol, 25, 505-11.
  5. Buldak RJ, Polaniak R, Buldak L, et al (2012). Short-term exposure to 50 Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells. Bioelectromagnetics, 33, 641-51.
  6. Cai Y, Kurita-Ochiai T, Hashizume T, et al (2013). Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis. Pathog Dis, 67, 76-83.
  7. Chen Y, Zhou M (1991). Free Radical Medicine. People's Military Medical Press. Beijing, 73-90.
  8. Dimri K, Pandey AK, Trehan R, et al (2013). Conventional radiotherapy with concurrent weekly cisplatin in locally advanced head and neck cancers of squamous cell origin - a single institution experience. Asian Pan J Cancer Prev, 14, 6883-8.
  9. Duan J, Lang Y, Song C, et al (2013). siRNA targeting of PRDX3 enhances cisplatin-induced apoptosis in ovarian cancer cells through the suppression of the NF-$\kappa{B}$ signaling pathway. Mol Med Rep, 7, 1688-94.
  10. Duh PD, Wang BS, Liou SJ, et al (2010). Cytoprotective effects of pu-erh tea on hepatotoxicity in vitro and in vivo induced by tert-butyl-hydroperoxide. Food Chem, 119, 580-5.
  11. Fabian E, Poloskey P, Kosa L, et al (2011). Activities of antioxidant enzymes in relation to oxidative and nitrosative challenges in childhood asthma. J Asthma, 48, 351-7.
  12. Fan JP, Fan C, Dong WM, et al (2013). Free radical scavenging and anti-oxidative activities of an ethanol-soluble pigment extract prepared from fermented Zijuan Pu-erh tea. Food Chem Toxicol, 59, 527-33.
  13. Gaona-Gaona L, Molina-Jijon E, Tapia E, et al (2011). Protective effect of sulforaphane pretreatment against cisplatin-induced liver and mitochondrial oxidant damage in rats. Toxicology, 286, 20-7.
  14. Garcia-Cortes M, Borraz Y, Lucena MI, et al (2008). Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig, 100, 688-95.
  15. Ghorbani A, Omidvar B, Parsi A (2013). Protective effect of selenium on cisplatin induced nephrotoxicity: A doubleblind controlled randomized clinical trial. J Nephropathol, 2, 129-34.
  16. Gupta RK, Singh N (2013). Morinda citrifolia (Noni) alters oxidative stress marker and antioxidant activity in cervical cancer cell lines. Asian Pac J Cancer Prev, 14, 4603-6.
  17. Gurocak S, Karabulut E, Karadag N, et al (2013). Preventive effects of resveratrol against azoxymethane induced damage in rat liver. Asian Pac J Cancer Prev, 14, 2367-70.
  18. Haidari F, Omidian K, Rafiei H, et al (2013). Green tea (Camellia sinensis) supplementation to diabetic rats improves serum and hepatic oxidative stress markers. Iran J Pharm Res, 12, 109-14.
  19. Hou Y, Shao W, Xiao R, et al (2009). Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model. Exp Gerontol, 44, 434-9.
  20. Johns NP, Johns JR (2012). Assessment of 8-isoprostane (8-$isoPGF2\alpha$) in urine of non-small cell lung cancer (NSCLC) patients undergoing chemotherapy. Asian Pac J Cancer Prev, 13, 775-80.
  21. Jung SH, Kim HJ, Oh GS, et al (2014). Capsaicin ameliorates cisplatin-induced renal injury through induction of heme oxygenase-1. Mol Cells, 37, 234-40.
  22. Li C (2008). Replication of Animal Models for Human Diseases. People's Medical Publishing House. Beijing, 495.
  23. Luo XM, Hu YH, Yu J, et al (1999). Effects of tea polyphenols on microcirculation and antioxidation in aircrew. Space Med Med Eng (Beijing), 12, 338-41.
  24. Mehdi WA, Zainulabdeen JA, Mehde AA (2013). Investigation of the antioxidant status in multiple myeloma patients: effects of therapy. Asian Pac J Cancer Prev, 14, 3663-7.
  25. Naqshbandi A, Khan W, Rizwan S, et al (2012). Studies on the protective effect of flaxseed oil on cislatin-induced hepatotoxicity. Hum Exp Toxicol, 31, 364-75.
  26. Nasr AY (2013). Morphological, biochemical, histological, and ultrastructural protective effects of misoprostol on cisplatin induced-hepatotoxicity in adult male rats. Saudi Med J, 34, 1237-47.
  27. Palipoch S, Punsawad C, Koomhin P, et al (2014). Hepatoprotective effect of curcumin and alpha-tocopherol against cisplatin-induced oxidative stress. BMC Complement Altern Med, 14, 111.
  28. Pandurangan AK, Periasamy S, Anandasadagopan SK, Ganapasam S, Srinivasalu SD (2012). Green tea polyphenol protection against 4-nitroquinoline 1-oxide-induced bone marrow lipid peroxidation and genotoxicity in Wistar rats. Asian Pac J Cancer Prev, 13, 4107-12.
  29. Pfister D, Brehmer B, Thuer D, et al (2010). Optimizing treatment of advanced testicular germ cell tumors. Urologe A, 49, 1120, 1-3.
  30. Rodrigues FA, Prata MM, Oliveira IC, et al (2014). Gingerol Fraction from Zingiber officinale Protects against Gentamicin-Induced Nephrotoxicity. Antimicrob Agents Chemother, 58, 1872-8.
  31. Sahu BD, Rentam KK, Putcha UK, et al (2011). Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Food Chem Toxicol, 49, 3090-7.
  32. Sudhakar D, Krishna Kishore R, Parthasarathy PR (2010). Portulaca oleracea L. extract ameliorates the cisplatininduced toxicity in chick embryonic liver. Indian J Biochem Biophys, 47, 185-9.
  33. Wang D, Luo X, Zhong Y, et al (2012). Pu-erh black tea extract supplementation attenuates the oxidative DNA damage and oxidative stress in Sprague-Dawley rats with renal dysfunction induced by subchronic 3-methyl-2-quinoxalin benzenevinylketo-1, 4-dioxide exposure. Food Chem Toxicol, 50, 147-54.
  34. Wang D, Zhong Y, Luo X, et al (2011). Pu-erh black tea supplementation decreases quinocetone-induced ROS generation and oxidative DNA damage in Balb/c mice. Food Chem Toxicol, 49, 477-84.
  35. Wang KP, Bai Y, Wang J, et al (2014). Inhibitory effects of Schisandra chinensis on acetaminophen-induced hepatotoxicity. Mol Med Rep, 9, 1813-9.
  36. Wang Z, Li L, Zheng F, et al (2011). Correlation between the amplitude of glucose excursion and the oxidative/antioxidative system in subjects with different types of glucose regulation. Biomed Environ Sci, 24, 68-73.
  37. Zhao JA, Peng L, Geng CZ, et al (2014). Preventive effect of hydrazinocurcumin on carcinogenesis of diethylnitrosamineinduced hepatocarcinoma in male SD rats. Asian Pac J Cancer Prev, 15, 2115-21.
  38. Zhao YM, Gao LP, Zhang HL, et al (2014). Grape seed proanthocyanidin extract prevents DDP-induced testicular toxicity in rats. Food Funct, 5, 605-11.

Cited by

  1. Prospecting major genes in dairy buffaloes vol.16, pp.1, 2015,
  2. Pu-erh Tea Water Extract Mediates Cell Cycle Arrest and Apoptosis in MDA-MB-231 Human Breast Cancer Cells vol.8, pp.1663-9812, 2017,
  3. Anti-Obesity, Anti-Atherosclerotic and Anti-Oxidant Effects of Pu-Erh Tea on a High Fat Diet-Induced Obese Rat Model vol.07, pp.02, 2019,
  4. Ripe and Raw Pu-Erh Tea: LC-MS Profiling, Antioxidant Capacity and Enzyme Inhibition Activities of Aqueous and Hydro-Alcoholic Extracts vol.24, pp.3, 2019,